[{"address1": "16 Abba Hillel Road", "city": "Ramat Gan", "zip": "5250608", "country": "Israel", "phone": "972 3 693 8448", "fax": "972 3 6938447", "website": "https://www.galmedpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Allen  Baharaff", "age": 59, "title": "Co-Founder, President, CEO & Chairman", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1467116, "exercisedValue": 0, "unexercisedValue": 4940}, {"maxAge": 1, "name": "Mr. Doron  Cohen", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 252093, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Guy  Nehemya", "age": 39, "title": "COO & Data Protection Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 294347, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yohai  Stenzler CPA", "age": 41, "title": "Chief Accounting Officer", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 298107, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Liat  Hayardeny MBA, Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tali  Gorfine", "age": 54, "title": "Medical Consultant", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 202763, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.29, "open": 1.25, "dayLow": 1.21, "dayHigh": 1.2753, "regularMarketPreviousClose": 1.29, "regularMarketOpen": 1.25, "regularMarketDayLow": 1.21, "regularMarketDayHigh": 1.2753, "payoutRatio": 0.0, "beta": 0.491, "forwardPE": -1.2045631, "volume": 327897, "regularMarketVolume": 327897, "averageVolume": 2419916, "averageVolume10days": 9317500, "averageDailyVolume10Day": 9317500, "bid": 0.9144, "ask": 1.57, "bidSize": 2, "askSize": 2, "marketCap": 2801537, "fiftyTwoWeekLow": 1.15, "fiftyTwoWeekHigh": 23.8, "fiftyDayAverage": 1.6686, "twoHundredDayAverage": 3.147815, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -12418136, "profitMargins": 0.0, "floatShares": 2015115, "sharesOutstanding": 2258030, "sharesShort": 96430, "sharesShortPriorMonth": 48498, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0427, "heldPercentInsiders": 0.028959999, "heldPercentInstitutions": 0.02059, "shortRatio": 0.04, "shortPercentOfFloat": 0.044, "impliedSharesOutstanding": 2258030, "bookValue": 9.807, "priceToBook": 0.12651168, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -7517000, "trailingEps": -8.08, "forwardEps": -1.03, "lastSplitFactor": "1:12", "lastSplitDate": 1724976000, "enterpriseToEbitda": 2.005, "52WeekChange": -0.7409638, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 1.2407, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 15331000, "totalCashPerShare": 6.79, "ebitda": -6195000, "totalDebt": 0, "quickRatio": 7.151, "currentRatio": 7.42, "returnOnAssets": -0.22339001, "returnOnEquity": -0.49772, "freeCashflow": -4423000, "operatingCashflow": -5880000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GLMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Galmed Pharmaceuticals Ltd.", "shortName": "Galmed Pharmaceuticals Ltd.", "marketState": "REGULAR", "exchange": "NCM", "messageBoardId": "finmb_114779940", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.821702, "regularMarketPrice": 1.2407, "corporateActions": [], "regularMarketTime": 1746723129, "fiftyTwoWeekChangePercent": -74.09638, "earningsTimestamp": 1743624601, "earningsTimestampStart": 1748462400, "earningsTimestampEnd": 1748894400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -8.08, "epsForward": -1.03, "fiftyDayAverageChange": -0.42789996, "fiftyDayAverageChangePercent": -0.25644252, "twoHundredDayAverageChange": -1.907115, "twoHundredDayAverageChangePercent": -0.60585356, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "3.0 - Hold", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1394717400000, "regularMarketChange": -0.049299955, "regularMarketDayRange": "1.21 - 1.2753", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2419916, "fiftyTwoWeekLowChange": 0.09070003, "fiftyTwoWeekLowChangePercent": 0.078869596, "fiftyTwoWeekRange": "1.15 - 23.8", "fiftyTwoWeekHighChange": -22.5593, "fiftyTwoWeekHighChangePercent": -0.9478698, "displayName": "Galmed Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]